Calithera Biosciences Inc (CALA)

6.02 +0.28  +4.88% NASDAQ Apr 8, 20:00 Delayed 2m USD

Calithera Biosciences Total Assets (Quarterly):

168.77M for Dec. 31, 2019
View 4,000+ financial data types
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 2013. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 168.77M
Sept. 30, 2019 146.32M
June 30, 2019 166.38M
March 31, 2019 131.91M
Dec. 31, 2018 142.72M
Sept. 30, 2018 147.67M
June 30, 2018 158.98M
March 31, 2018 178.58M
Dec. 31, 2017 192.46M
Sept. 30, 2017 205.54M
June 30, 2017 214.08M
March 31, 2017 223.91M
Dec. 31, 2016 54.80M
Sept. 30, 2016 58.92M
June 30, 2016 63.23M
March 31, 2016 71.56M
Dec. 31, 2015 75.75M
Sept. 30, 2015 84.53M
June 30, 2015 90.75M
March 31, 2015 96.87M
Dec. 31, 2014 104.77M
Sept. 30, 2014 39.64M
June 30, 2014 30.66M
Dec. 31, 2013 34.84M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

Intercept Pharmaceuticals Inc 754.89M
ACADIA Pharmaceuticals Inc 783.18M
Karyopharm Therapeutics Inc 294.96M

Total Assets (Quarterly) Range, Past 5 Years

Minimum 54.80M Dec 2016
Maximum 223.91M Mar 2017
Average 135.62M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.